Global Smart Pills Market to Reach USD 8.9 Billion by 2033, Catalyzed by Escalating Demand for Minimally Invasive (MI) Procedures

December 18, 2024 | Healthcare

IMARC Group’s latest report, titled “Smart Pills Market Report by Target Area (Esophagus, Small Intestine, Large Intestine, Stomach), Disease Indication (Esophageal Diseases, Small Bowel Diseases, Colon Diseases, and Others), Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring), End User (Hospitals, Diagnostic Centers, Research Institutes), and Region 2025-2033,” finds that the global smart pills market size reached USD 4.9 Billion in 2024. Smart pills, also known as digital pills, refer to ingestible, miniaturized electronic devices designed in the shape of pharmaceutical capsules. They consist of sensors, trackers, cameras, and patches that assist in recording various physiological measures accurately. Once swallowed, these pills move along the gastrointestinal (GI) tract to send vital information that is otherwise difficult to obtain and then gets eliminated from the system easily. They offer a thorough examination of the GI tract and other body parts and perform highly advanced functions, including sensing, imaging, and drug delivery. As a result, smart pills have gained immense traction in the healthcare industry to aid in better diagnostics, therapeutics, and monitoring while eliminating the need for invasive procedures. 


Global Smart Pills Market Trends:

The escalating demand for minimally invasive (MI) procedures and the surging prevalence of chronic diseases, such as gastrointestinal (GI) disorders, colon cancer, and inflammatory bowel disease (IBD), represent the primary factors driving the market growth. In addition, smart pills are rapidly replacing several traditional techniques, including endoscopy and colonoscopy, for GI diagnosis due to their enhanced patient comfort and ability to offer accurate, multidimensional images of numerous internal body parts. Apart from this, the growing inclination toward telemedicine technologies for remote patient visits due to the recent coronavirus disease (COVID-19) outbreak has augmented the demand for smart pills. Furthermore, the leading manufacturers are launching innovative product variants with improved batteries and onboard memory to assist in telemedicine and remote patient monitoring, provide real-time, wireless information, and measure the effects of medications. Besides this, the increasing investments in research and development (R&D) projects focusing on effective localization, steering, and control of pills are offering lucrative opportunities to the market players. Other factors, including the expanding pediatric and geriatric population, rising approvals of new pills, surging demand for advanced drug delivery systems, and technological advancements, are also providing a positive thrust to the market growth. Looking forward, IMARC Group expects the market value to reach USD 8.9 Billion by 2033, growing at a CAGR of 6.55% during the forecast period (2025-2033).


Market Summary:

  • Based on the target area, the market has been categorized into esophagus, small intestine, large intestine, and stomach.
  • The market has been divided based on the disease indication into esophageal diseases, small bowel diseases, colon diseases, and others.
  • On the basis of the application, the market has been classified into capsule endoscopy, drug delivery, and patient monitoring.
  • Based on the end user, the market has been segregated into hospitals, diagnostic centers, and research institutes.
  • Region-wise, the market has been segmented into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
  • The competitive landscape of the market has also been examined, with some of the key players being CapsoVision Inc., Check-Cap Ltd., General Electric Company, IntroMedic Co. Ltd., Jinshan Science & Technology (Group) Co. Ltd., Koninklijke Philips N.V., Medtronic plc, Olympus Corporation, and PENTAX Medical (Hoya Corporation).


Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Billion USD
Segment Coverage Target Area, Disease Indication, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered CapsoVision Inc., Check-Cap Ltd., General Electric Company, IntroMedic Co. Ltd., Jinshan Science & Technology (Group) Co. Ltd., Koninklijke Philips N.V., Medtronic plc, Olympus Corporation and PENTAX Medical (Hoya Corporation)
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Smart Pills Market to Reach USD 8.9 Billion by 2033, Catalyzed by Escalating Demand for Minimally Invasive (MI) Procedures
Purchase Options Discount
Offer
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials